Century Therapeutics (IPSC) Profit After Tax (2020 - 2026)
Century Therapeutics (IPSC) reported Profit After Tax of -$21.6 million for Q1 2026, down 128.27% year-over-year from $76.6 million in Q1 2025, and down 12.79% quarter-over-quarter from -$19.2 million in Q4 2025.
Century Therapeutics (IPSC) Profit After Tax (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Profit After Tax data on file, last reported at -$21.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$21.6 million, down 128.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$107.8 million (down 391.2% YoY), and the FY2025 annual result was -$9.6 million, up 92.42% from the prior year.
- Profit After Tax retreated to -$21.6 million in Q1 2026 per IPSC's latest filing, from -$19.2 million in the prior quarter.
- Over five years, Profit After Tax peaked at $76.6 million in Q1 2025 and troughed at -$39.4 million in Q4 2023.
- A 5-year average of -$25.0 million and a median of -$31.3 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax soared 372.82% in 2025, then plunged 128.27% in 2026.
- A 5-year view of Profit After Tax shows it stood at -$31.7 million in 2022, then declined by 24.35% to -$39.4 million in 2023, then rose by 8.44% to -$36.1 million in 2024, then surged by 46.8% to -$19.2 million in 2025, then decreased by 12.79% to -$21.6 million in 2026.
- Business Quant data shows IPSC's Profit After Tax at -$21.6 million in Q1 2026, -$19.2 million in Q4 2025, and -$34.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | -21.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.65 Mn |
| Dec 31, 2025 | -19.19 Mn |
| Sep 30, 2025 | -34.42 Mn |
| Jun 30, 2025 | -32.54 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Dec 31, 2024 | -36.07 Mn |
| Sep 30, 2024 | -31.23 Mn |
| Jun 30, 2024 | -31.21 Mn |
| Mar 31, 2024 | -28.06 Mn |
| Dec 31, 2023 | -39.40 Mn |
| Sep 30, 2023 | -32.72 Mn |
| Jun 30, 2023 | -33.29 Mn |
| Mar 31, 2023 | -31.26 Mn |
| Dec 31, 2022 | -31.68 Mn |
| Sep 30, 2022 | -30.75 Mn |
| Jun 30, 2022 | -30.99 Mn |
| Mar 31, 2022 | -37.51 Mn |
| Dec 31, 2021 | -28.19 Mn |
| Sep 30, 2021 | -26.01 Mn |
| Jun 30, 2021 | -23.27 Mn |